Learn more about using Bormed resin concentrates in medical devices, diagnostics and pharmaceutical packaging Power Tool Battery Pack Maxxam™ FR Formulation provided flame retardent and HDPE based solution for power tool battery pack

Learn more about using Bormed resin concentrates in medical devices, diagnostics and pharmaceutical packaging Power Tool Battery Pack Maxxam™ FR Formulation provided flame retardent and HDPE based solution for power tool battery pack

The Company does not provide reconciliations of forward-looking non-GAAP financial measures, such as outlook for adjusted EBITDA, adjusted earnings per share, adjusted operating income and free cash flow, to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 83% Median: 76% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $510M and excludes one-time synergy capture CAPEX ($20M) 85 87 86 86 81 81 59 92 88 81 79 79 79 76 76 75 73 67 67 64 60 7 Total Enterprise Value / 2021E EBITDA Our current valuation implies an EBITDA multiple that is significantly below specialty formulator peers and our historic valuations, when the company had considerable exposure to more cyclical and challenging end markets. Free Cash Flow Calculation Year Ended Cash provided (used) by operating activities $ 221.6 Capital expenditures (63.7) Free Cash Flow 157.9 Payment of post-acquisition date earnout liability 38.1 Taxes paid on gain on divestiture 142.0 Adjusted Free Cash Flow $ 338.0 Free Cash Flow Calculation Total Discontinued Operations Continuing Operations Cash provided by operating activities $ 300.8 $ 74.4 $ 226.4 Capital expenditures 81.7 14.1 67.6 Free Cash Flow $ 219.1 $ 60.3 $ 158.8 Avient Q4 Earnings and 2021 Outlook.pdf Avient February IR Presentation.pdf Avient IR Presentation - Goldman Sachs and Morgan Stanley - Website.pdf Avient Q4 Earnings and 2021 Outlook.pdf Avient Q4 Earnings and 2021 Outlook.pdf Avient Q4 Earnings and 2021 Outlook.pdf Avient Q4 Earnings and 2021 Outlook.pdf Avient Q4 Earnings and 2021 Outlook.pdf 2.5.21 IR Deck Attachments clean

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without any limitation, any supply chain and logistics issues; • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and • Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2020 under Item 1A, “Risk Factors.” The Company does not provide reconciliations of forward-looking non-GAAP financial measures, such as outlook for Adjusted EBITDA, Adjusted Earnings Per Share, Adjusted Operating Income and Free Cash Flow, to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $635M and estimated CAPEX of $90M (excludes IT system upgrade of $25M and synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of February 15, 2022 86 89 85 80 76 76 89 85 79 78 76 76 76 70 69 63 8 LB Source: Peer data per Bloomberg market data as of February 15, 2022 Total Enterprise Value / 2022E EBITDAWith the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets.

They are suitable for specialty medical devices, surgical devices, and other vital healthcare applications.

Connected medical devices are transforming the way care is delivered. Designed to help you overcome challenges for healthcare devices and applications

GUANGZHOU, China – PolyOne announced today at Chinaplas 2017 that COMPTEK™ blends based on polyetheretherketone (PEEK) are now available in Asia for multi-use medical devices, electrical connectors, and other demanding applications. The medical device manufacturing sector across Asia is growing quickly, and this region is also the clear leader in the manufacturing and export of electronics,” said Barto Du Plessis, vice president Asia, at PolyOne.

NEUTM Express Service: Delivering speed to customers’ R&D process with rapid prototyping and sampling of customized materials for a multitude of in-vivo devices Trilliant™ HC Thermoplastics: High-performance formulations with excellent chemical resistance and durability for medical device enclosures; available in standard grades or customized formulations from an array of base polymers 

Its exhibit will include application successes covering drug delivery, diagnostics, pharmaceutical packaging, and surgical devices.     Colorant Chromatics white colorants for high temperature polymers such as PPSU, PES, PSU and PEI to enhance aesthetics and performance of medical devices

We enable our customers to reach their goals – improving patient outcomes with life-saving medical devices that incorporate more durable materials.” Developed as a drop-in replacement for FR PC/ABS, this innovative Trilliant HC formulation was recently used successfully by a medical device OEM seeking to improve resistance to cracking and brittleness for its housings.